SLC7A11 and triple-negative breast carcinoma: Overexpression of xCT/SLC7A11 has been reported in triple-negative breast cancer (TNBC), where its activity fuels cysteine supply for GSH production; conversely, xCT inhibition reduces proliferation, partly through GSH depletion (37).